Development of an 8-plex Luminex assay to detect swine cytokines for vaccine development: Assessment of immunity after porcine reproductive and respiratory syndrome virus (PRRSV) vaccination

Vaccine

Volumn 28, Issue 32, 2010, Pages 5356-5364

  Lawson, Steven ^a   Lunney, Joan ^b   Zuckermann, Federico ^c   Osorio, Fernando ^d   Nelson, Eric ^a   Welbon, Craig ^a   Clement, Travis ^a   Fang, Ying ^a   Wong, Susan ^e   Kulas, Karen ^e   Christopher Hennings, Jane ^a  

^a SOUTH DAKOTA STATE UNIVERSITY   (United States)

^b AGRICULTURAL RESEARCH SERVICE   (United States)

^c UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^d UNIVERSITY OF NEBRASKA LINCOLN   (United States)

^e WADSWORTH CENTER   (United States)

Author keywords

Luminex; PRRSV; Swine cytokines

Indexed keywords

ALPHA INTERFERON; GAMMA INTERFERON; GLYCOPROTEIN; GLYCOPROTEIN V; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 8; PORCINE REPRODUCTIVE AND RESPIRATORY VIRUS VACCINE; PYRSVAC 183; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VIRUS VACCINE; CYTOKINE; GLYCOPROTEIN 5, PRRSV; MICROSPHERE; MONOCLONAL ANTIBODY; VIRUS ENVELOPE PROTEIN;

8 PLEX LUMINEX ASSAY; ARTICLE; CONTROLLED STUDY; CROSS REACTION; CYTOKINE PRODUCTION; IMMUNOASSAY; INNATE IMMUNITY; NONHUMAN; PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TH1 CELL; TH2 CELL; VACCINATION; VIRUS ISOLATION; VIRUS STRAIN; ANIMAL; BLOOD; CHEMISTRY; COMPARATIVE STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUOROIMMUNOASSAY; IMMUNOLOGY; PROCEDURES; REPRODUCIBILITY; SWINE;

ANIMALS; ANTIBODIES, MONOCLONAL; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLUOROIMMUNOASSAY; MICROSPHERES; PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME; REPRODUCIBILITY OF RESULTS; SWINE; VIRAL ENVELOPE PROTEINS; VIRAL VACCINES;

EID: 77954951437     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.05.016     Document Type: Article

References (32)

1. Tian K., Yu X., Zhao T., Feng Y., Cao Z., Yang C., et al. Emergence of fatal PRRSV variants: unparalleled outbreaks of atypical PRRS in China and molecular dissection of the unique hallmark. PLoS ONE 2007, 2(6):e526. 10.1371/journal.pone.0000526.
2. Lager K.M., Mengeling W.L., Brockmeier S.L. Evaluation of protective immunity in gilts inoculated with the NADC-8 isolate of porcine reproductive and respiratory syndrome virus (PRRSV) and challenge-exposed with an antigenically distinct PRRSV isolate. Am J Vet Res 1999, 60:1022-1027.
3. Kimman T.G., Cornelissen L.A., Moormann R.J., Rebel J.M.J., Stockhofe-Zurwieden N. Challenges for porcine reproductive and respiratory syndrome virus (PRRSV) vaccinology. Vaccine 2009, 27:3704-3718.
4. VanReeth K., Labarque G., Nauwynck H. Differential production of proinflammatory cytokines in the pig lung during different respiratory virus infection: correlations with pathogenicity. Res Vet Sci 1999, 67:47-52.
5. Meier W.A., Galeota J., Osorio F.A., Husmann R.J., Schnitzlein W., Zuckermann F.A. Gradual development of the interferon-gamma and antibody responses of swine to porcine reproductive and respiratory syndrome virus. Virology 2003, 309:18-31.
6. Charerntantanakul W. Adjuvants for porcine reproductive and respiratory syndrome virus vaccines. Vet Immunol Immunopathol 2009, 129:1-13.
7. MacLachlan J., Balasuriya U.B., Hedges J.F., Schweidler T.M., McCollum W.H., Timoney P.J., et al. Serologic response of horses to the structural proteins of equine arteritis virus. J Vet Diagn Invest 1998, 10:229-236.
8. Zuckermann F.A., Garcia E.A., Luque I., Christopher-Hennings J., Doster A., Brito M., et al. Assessment of the efficacy of commercial porcine reproductive and respiratory syndrome virus (PRRSV) vaccines based on measurement of serologic response, frequency of gamma-IFN-producing cells and virological parameters of protection upon challenge. Vet Microbiol 2007, 123:69-85.
9. Kohlmeier J.E., Woodland D.L. Immunity to respiratory viruses. Annu Rev Immunol 2009, 27:61-82.
10. Johannisson A., Jonasson R., Dernfalk J., Jensen-Waern M. Simultaneous detection of porcine proinflammatory cytokines using multiplex flow cytometry by the xMAP technology. Int Soc Anal Cytol 2006, 69A:391-395.
11. Bjerre M., Hansen T., Flyvbjerg A., Tønnesen E. Simultaneous detection of porcine cytokines by multiplex analysis: development of magnetic bioplex assay. Vet Immunol Immunopathol 2009, 130:53-58.
12. Grabarek Z., Gergely J. Zero-length crosslinking procedure with the use of active esters. Anal Biochem 1990, 185:131-135.
13. Kellar K.L., Janine P.D. Multiplexed microsphere-based flow cytometric immunoassays for human cytokines. J Immunol Methods 2003, 279:277-285.
14. Kellar K.L., Kalwar R.R., Dubois K.A., Crouse D., Chafin W.D., Kane B.-E. Multiplexed fluorescent bead-based immunoassays for quantitation of human cytokines in serum and culture supernatants. Cytometry 2001, 45:27.
15. Azevedo M., Yan L., Pouly S., Gonzales A., Jeong K., Nguyen T., et al. Cytokine responses in gnotobiotic pigs after infection with virulent or attenuated human rotavirus. J Virol 2006, 80:372-382.
16. Audonnet J, Bublot M, Perez J, Baudu P. United States Patent Application 20,030,003,112; 2001.
17. Meier W.A., Husman R.J., Schnitzlein W.M., Osorio F.A., Lunney J.K., Zuckermann F.A. Cytokines and synthetic double-stranded RNA augment the T helper 1 immune response of swine to porcine reproductive and respiratory syndrome virus. Vet Immunol Immunopathol 2004, 102:299-314.
18. Charerntantanakul W., Platt R., Johnson W., Roof M., Vaughn E., Roth J.A. Immune responses and protection by vaccine and various vaccine adjuvant candidates to virulent porcine reproductive and respiratory syndrome virus. Vet Immunol Immunopathol 2006, 109:99-115.
19. Díaz I., Darwich L., Pappaterra G., Pujols J., Mateu E. Immune responses of pigs after experimental infection with a European strain of porcine reproductive and respiratory syndrome virus. J Gen Virol 2005, 86:1943-1951.
20. Mateu E., Diaz I. The challenge of PRRS immunology. Vet J 2008, 177:345-351.
21. Royaee A.R., Husmann R.J., Dawson H.D., Calzada-Nova G., Schnitzlein W.M., Zuckermann F.A., et al. Deciphering the involvement of innate immune factors in the development of the host response to PRRSV vaccination. Vet Immunol Immunopathol 2004, 102(3):199-216.
22. Chan S.H., Perussia J.W., Gupta M., Kobayashi M., Pospisil M., Young H.A., et al. Induction of interferon γ production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers. J Exp Med 1991, 173:869-879.
23. Sher A., Jankovic D., Cheever A., Wynn T. An IL-12 based vaccine approach for preventing immunopathology in schistomosomiasis. Ann N Y Acad Sci 1996, 795:202-207.
24. Yamanaka H., Hoyt T., Bowen R., Yang X., Crist K., Golden S., et al. An IL-12 DNA vaccine co-expressing Yersinia pestis antigens protects against pneumonic plague. Vaccine 2009, 27:30-87.
25. Hirao L.A., Wu L., Khan A.S., Dai A., Karl J., Lank S., et al. DNA vaccination with IL-12 lowers viral replication following SIVmac251 challenge. Retrovirology 2009, P28.
26. Solano-Aguilar G.I., Zarlenga D., Beshah E., Vengroski K., Gasbarre L., Junker D., et al. Limited effect of recombinant porcine interleukin-12 on porcine lymphocytes due to a low level of IL-12 β2 receptor. Vet Immunol Immunopathol 2002, 89:133-148.
27. high. Viral Immunol 2009, 22:261-271.
28. Foss D.L., Zilliox M.J., Meier W., Zuckermann F., Murtaugh M.P. Adjuvant danger signals increase the immune response to porcine reproductive and respiratory syndrome virus. Viral Immunol 2002, 15:557-566.
29. Carter Q., Curiel R. Interleukin-12 (IL-12) ameliorates the effects of porcine respiratory and reproductive syndrome virus (PRRSV) infection. Vet Immunol Immunopathol 2005, 107:105-118.
30. Rossio J.L., Gearing A.J.H. Measurement of cytokines. Clinical applications of cytokines, role in pathogenesis, diagnosis and therapy 1993, 19. Oxford University Press. J.J. Oppenheim, A.J.H. Gearing (Eds.).
31. Martelli P., Gozio S., Ferrari L., Rosina S., De Angelis E., Quintavalla C., et al. Efficacy of a modified live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine in pigs naturally exposed to a heterologous European (Italian cluster) field strain: clinical protection and cell mediated immunity. Vaccine 2009, 27:3788-3799.
32. Murtaugh M.P., Johnson C.R., Xiao Z., Scamurra R.W., Zhou Y. Species specialization in cytokine biology: is interleukin-4 central to the T (H)1-T (H)2 paradigm in swine?. Dev Comp Immunol 2009, 33:344-352.